Characterization of magnetic hydroxyapatite nanocrystallites and potential application for MRI contrast agent

Current Nanoscience

Volumn 7, Issue 6, 2011, Pages 902-907

  Wu, Hsi Chin ^a   Wang, Tzu Wei ^b   Lin, Feng Huei ^c,d   Sun, Jui Sheng ^e  

^a TATUNG UNIVERSITY   (Taiwan)

^b NATIONAL TSING HUA UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^d NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^e NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Contrast agent; Hydroxyapatite; Magnetic; Nanoparticles

Indexed keywords

COMPOSITION ANALYSIS; CONTRAST AGENT; CULTURED CELL; ENERGY DISPERSIVE X-RAY SPECTROSCOPY; FOURIER TRANSFORM INFRARED; IRON IONS; IRON PRECURSORS; MAGNETIC; MAGNETIZATION PROPERTY; MRI CONTRAST AGENTS; NEEDLE-LIKE; PARTICLE MORPHOLOGIES; PHYSICOCHEMICAL PROPERTY; POTENTIAL APPLICATIONS; SPHERE SHAPE; SUPERCONDUCTING QUANTUM INTERFERENCE DEVICE; SUPERPARAMAGNETIC PROPERTY; SYNTHETIC HYDROXYAPATITE; TOXIC EFFECT; WET CHEMICAL PROCESS;

APATITE; BIOCOMPATIBILITY; CRYSTAL STRUCTURE; CRYSTALLITES; ENERGY DISPERSIVE SPECTROSCOPY; EPITAXIAL GROWTH; FUNCTIONAL GROUPS; HYDROXYAPATITE; MAGNETIZATION; METAL IONS; NANOPARTICLES; QUANTUM INTERFERENCE DEVICES; SPHERES; SQUIDS; SUPERPARAMAGNETISM; TRANSMISSION ELECTRON MICROSCOPY; X RAY DIFFRACTION; X RAY DIFFRACTION ANALYSIS;

NANOMAGNETICS;

HYDROXYAPATITE; LACTATE DEHYDROGENASE; MAGNETIC HYDROXYAPATITE NANOPARTICLE; MAGNETIC NANOPARTICLE; MAGNETITE; NANOCRYSTAL; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BIOCOMPATIBILITY; CELL CULTURE; CELL STRAIN 3T3; CHEMICAL COMPOSITION; CONTROLLED STUDY; CRYSTAL STRUCTURE; CYTOTOXICITY TEST; EMBRYO; INFRARED SPECTROSCOPY; MAGNETISM; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PARTICLE SIZE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPE; TRANSMISSION ELECTRON MICROSCOPY; X RAY DIFFRACTION; X RAY SPECTROMETRY;

EID: 82155171436     PISSN: 15734137     EISSN: 18756786     Source Type: Journal    
DOI: 10.2174/157341311798220754     Document Type: Article

References (22)

1. Mornet, S.; Vasseur, S.; Grasset, F.; Duguet, E., Magnetic nanoparticle design for medical diagnosis and therapy. J. Mater. Chem., 2004, 14(14), 2161-2175.
2. Veiseh, O.; Gunn, J. W.; Zhang, M., Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging. Adv. Drug Deliv. Rev., 2010, 62(3), 284-304.
3. Takemoto, S.; Kusudo, Y.; Tsuru, K.; Hayakawa, S.; Osaka, A.; Takashima, S., Selective protein adsorption and blood compatibility of hydroxy-carbonate apatites. J. Biomed. Mater. Res. A, 2004, 69(3), 544-51;
4. Fujii, E.; Ohkubo, M.; Tsuru, K.; Hayakawa, S.; Osaka, A.; Kawabata, K.; Bonhomme, C.; Babonneau, F., Selective protein adsorption property and characterization of nano-crystalline zinc-containing hydroxyapatite. Acta Biomater., 2006, 2(1), 69-74.
5. Hong, Z.; Zhang, P.; He, C.; Qiu, X.; Liu, A.; Chen, L.; Chen, X.; Jing, X., Nano-composite of poly(L-lactide) and surface grafted hydroxyapatite: mechanical properties and biocompatibility. Biomaterials, 2005, 26(32), 6296-304
6. Ahn, E. S.; Gleason, N. J.; Nakahira, A.; Ying, J. Y., Nanostructure processing of hydroxyapatite-based bioceramics. Nano. Lett., 2001, 1(3), 149-153.
7. Furuzono, T.; Masuda, M.; Okada, M.; Yasuda, S.; Kadono, H.; Tanaka, R.; Miyatake, K., Increase in cell adhesiveness on a poly(ethylene terephthalate) fabric by sintered hydroxyapatite nanocrystal coating in the development of an artificial blood vessel. ASAIO J., 2006, 52(3), 315-320
8. Dash, A. K.; Cudworth, G. C., 2nd, Therapeutic applications of implantable drug delivery systems. J. Pharmacol. Toxicol. Methods, 1998, 40 (1), 1-12.
9. Aoki, H., What is hydroxyapatite? In: Medical Applications of Hydroxyapatite. Takayama press: Tokyo, 1994; pp 1-12.
10. Misono, M.; Hall, W. K., Oxidation-reduction properties of copper-and nickel-substituted hydroxyapatites. J. Phys. Chem., 1973, 77(6), 791-800.
11. Wakamura, M.; Kandori, K.; Ishikawa, T., Surface structure and composition of calcium hydroxyapatites substituted with Al(III), La(III) and Fe(III) ions. Colloid Surf. A-Physicochem. Eng. Asp., 2000, 164(2-3), 297-305.
12. Wakamura, M.; Kandori, K.; Ishikawa, T., Surface composition of calcium hydroxyapatite modified with metal ions. Colloid Surf. A-Physicochem. Eng. Asp., 1998, 142(1), 107-116.
13. Mizushima, Y.; Ikoma, T.; Tanaka, J.; Hoshi, K.; Ishihara, T.; Ogawa, Y.; Ueno, A., Injectable porous hydroxyapatite microparticles as a new carrier for protein and lipophilic drugs. J. Control. Release, 2006, 110 (2), 260-265;
14. Dorozhkin, S. V., Nanosized and nanocrystalline calcium orthophosphates. Acta Biomater., 2010, 6(3), 715-34.
15. Siegel, R. W., Cluster-Assembled Nanophase Materials. Ann. Rev. Mater. Sci., 1991, 21, 559-578
16. Castro, D. T.; Ying, J. Y. In Synthesis and sintering of nanocrystalline titanium nitride, 1997; pp 67-70.
17. Wu, H. C.; Wang, T. W.; Sun, J. S.; Wang, W. H.; Lin, F. H., A novel biomagnetic nanoparticle based on hydroxyapatite. Nanotechnology, 2007, 18 (16).
18. Korzeniewski, C.; Callewaert, D. M., An enzyme-release assay for natural cytotoxicity. J. Immunol. Methods, 1983, 64(3), 313-20.
19. Spector, M., High resolution electron microscope study of lattice images in biological apatites. J. Microsc., 1975, 103(1), 55-62
20. Benezra Rosen, V.; Hobbs, L. W.; Spector, M., The ultrastructure of anorganic bovine bone and selected hydroxyapatites used as bone graft substitute materials. Biomaterials, 2001, 23, 921-928.
21. Stokes, R. J.; Evans, D. F., Fundamentals of Interfacial Engineering. Wiley- VCH Verlag GmbH: Weinheim, Germany, 1996; pp. 566-567.
22. Jeong, U.; Teng, X. W.; Wang, Y.; Yang, H.; Xia, Y. N., Superparamagnetic colloids: Controlled synthesis and niche applications. Adv. Mater., 2007, 19(1), 33-60